Exabis Library
Welcome to the e-CCO Library!
P697: De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P697: Examining the regulatory role of epigenetic and transcriptomic alterations in anti-TNF treatment response and disease progression in patients with Ulcerative Colitis
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P697: Thiopurines vs. anti-TNFa for the prevention of postoperative recurrence in Crohn’s disease—a meta-analysis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P698 IBD patients equally tolerate bowel preparation but need higher doses of sedation during colonoscopy in comparison with a population screening programme: Results from a prospective, single-centre study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P698: Early dose optimisation in non-responders to golimumab induction treatment for ulcerative colitis is supported by pharmacokinetic data
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P698: Mapping field cancerisation and clonal evolution in IBD colons with dysplasia and colorectal cancer
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P698: Persistence, clinical effectiveness and safety of vedolizumab in the post-marketing real clinical practice in Italy: a double-centre, 2-year experience in Crohn’s disease and ulcerative colitis patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P698: Role of an exclusion diet (reduced disaccharides, saturated fats, emulsifiers, red and ultraprocessed meats) in maintaining the remission of chronic inflammatory bowel diseases in adults
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P698: The risk of developing subsequent immune mediated inflammatory diseases: a retrospective matched cohort study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P699 The concordance of Short Form-36 Health Survey scores with Mayo scores in the tofacitinib ulcerative colitis clinical programme
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P699: Faecal microbiota transplantation as treatment for recurrent clostridium difficile infections: a single-centre experience
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P699: Impact of adalimumab's patient support program on clinical outcomes in inflammatory bowel diseases: results from the COMPANION study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P699: Machine Learning-based Prediction for Early Progression in Korean Crohn’s disease: Results from the IMPACT Study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P699: Radiologic response reduces the risk of small-bowel surgery in Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P699: Ustekinumab therapy after biologic failure in patients with Crohn's Disease – A real-world single centre experience
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P700 Effect of vitamin D in disease activity score and clinical relapse in patients with inflammatory bowel disease: A systematic review and meta-analysis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P700: A high CRP before surgery and early medical prophylaxis predict postoperative endoscopic Crohn’s disease recurrence
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P700: Epidemiology of genital lymphoedema as the initial presentation of paediatric Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P700: Perceptions towards established and emerging dietary therapies for Crohn's disease management among the adult patients: results from a questionnaire survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P700: The efficacy of colesevelam to treat bile acid malabsorption in Crohn's disease: data from TOPPIC trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM